Dr. Kristin Watson discusses the use of beta-blockers post-MI in patients without heart failure.
0:00-0:40: Intro
0:41-1:18: Introduction of Dr. Kristin Watson
1:19-6:40: Trial overview
6:41-10:46: Background of beta-blocker use post-MI
10:47-12:36: Kristin’s overall thoughts
12:37-14:49: Types of beta-blockers used
14:50-16:06: Final thoughts
16:07-16:49: Closing
References:
- Kim J, Kang D, Park H, et al. Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study. Eur Heart J. 2020; doi: 10.1093/eurheartj/ehaa376.
- Kukin A, Noel Z, and Watson K. Through the Decades: β-blocker Use and Outcomes in Acute Coronary Syndromes. Cardiol Rev. 2018;26(3):157-166. doi: 10.1097/CRD.0000000000000197.
- Snow PJ. Effect of propranolol in myocardial infarction. Lancet. 1965;2:551-3.
- Snow PJ. Treatment of acute myocardial infarction with propranolol. Am J Cardiol. 1966;18:458-62.
- Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385-90. doi: 10.1016/s0140-6736(00)04560-8.
- Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1622-32. doi: 10.1016/S0140-6736(05)67661-1.
CardioScripts 